KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $1.4 million.

  • Fulgent Genetics' Receivables - Other changed N/A to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2024, which is 3404.09% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Receivables - Other is $1.4 million.
  • Over the past 5 years, Fulgent Genetics' Receivables - Other peaked at $19.8 million during Q4 2022, and registered a low of $506000.0 during Q1 2021.
  • In the last 5 years, Fulgent Genetics' Receivables - Other had a median value of $1.4 million in 2025 and averaged $2.4 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 131382.75% in 2022, then crashed by 9335.05% in 2023.
  • Fulgent Genetics' Receivables - Other (Quarter) stood at $1.4 million in 2021, then skyrocketed by 1313.83% to $19.8 million in 2022, then tumbled by 93.35% to $1.3 million in 2023, then skyrocketed by 34.04% to $1.8 million in 2024, then fell by 20.7% to $1.4 million in 2025.
  • Its Receivables - Other stands at $1.4 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.5 million for Q1 2025.